|
|
Article: Genetically Modified Bacteria Technique Validated By Independent Study.(VION Pharmaceuticals Inc. reports on usage of genetically engineered Clostridia bacteria as an anticancer agent)
- Article from:
- Immunotherapy Weekly
- Article date:
- December 26, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 DEC 26 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., has reported that an independent preclinical study at Johns Hopkins University Oncology Center has validated the concept of using bacteria as anticancer agent and tumor-selective drug delivery agents.
The Hopkins study involved the administration of genetically engineered Clostridia bacteria into tumor-bearing mice. The bacteria were found mostly in tumors but not in normal tissues after being injected into the mice. Regardless of the route of administration, by intravenous injection or by direct injection into tumors, the bacteria colonized tumors and destroyed tumor cells.
When ...